90 related articles for article (PubMed ID: 23825222)
21. Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart.
Soini Y; Satta J; Määttä M; Autio-Harmainen H
J Pathol; 2001 Jun; 194(2):225-31. PubMed ID: 11400152
[TBL] [Abstract][Full Text] [Related]
22. Cardiac remodeling by fibrous tissue after infarction in rats.
Sun Y; Zhang JQ; Zhang J; Lamparter S
J Lab Clin Med; 2000 Apr; 135(4):316-23. PubMed ID: 10779047
[TBL] [Abstract][Full Text] [Related]
23. Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling.
Yarbrough WM; Mukherjee R; Escobar GP; Mingoia JT; Sample JA; Hendrick JW; Dowdy KB; McLean JE; Lowry AS; O'Neill TP; Spinale FG
Circulation; 2003 Oct; 108(14):1753-9. PubMed ID: 12975256
[TBL] [Abstract][Full Text] [Related]
24. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U
Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
[TBL] [Abstract][Full Text] [Related]
26. Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction.
Most P; Seifert H; Gao E; Funakoshi H; Völkers M; Heierhorst J; Remppis A; Pleger ST; DeGeorge BR; Eckhart AD; Feldman AM; Koch WJ
Circulation; 2006 Sep; 114(12):1258-68. PubMed ID: 16952982
[TBL] [Abstract][Full Text] [Related]
27. Promotion of astrocytoma cell invasion by micro RNA-22 targeting of tissue inhibitor of matrix metalloproteinase-2.
Ohnishi YI; Iwatsuki K; Ishihara M; Ohkawa T; Kinoshita M; Shinzawa K; Fujimoto Y; Yoshimine T
J Neurosurg Spine; 2017 Mar; 26(3):396-403. PubMed ID: 27834627
[TBL] [Abstract][Full Text] [Related]
28. Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice.
Matsumura S; Iwanaga S; Mochizuki S; Okamoto H; Ogawa S; Okada Y
J Clin Invest; 2005 Mar; 115(3):599-609. PubMed ID: 15711638
[TBL] [Abstract][Full Text] [Related]
29. The plasminogen-MMP system is more activated in the scar than in viable myocardium 3 months post-MI in the rat.
Gaertner R; Jacob MP; Prunier F; Angles-Cano E; Mercadier JJ; Michel JB
J Mol Cell Cardiol; 2005 Jan; 38(1):193-204. PubMed ID: 15623436
[TBL] [Abstract][Full Text] [Related]
30. Bendavia restores mitochondrial energy metabolism gene expression and suppresses cardiac fibrosis in the border zone of the infarcted heart.
Shi J; Dai W; Hale SL; Brown DA; Wang M; Han X; Kloner RA
Life Sci; 2015 Nov; 141():170-8. PubMed ID: 26431885
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin II receptor blockade improves matrix metalloproteinases/tissue inhibitor of matrix metalloproteinase-1 balance and restores fibronectin expression in rat infarcted myocardium.
Yang D; Ma S; Li D; Tang B; Yang Y
Biochem Biophys Res Commun; 2009 Oct; 388(3):606-11. PubMed ID: 19695229
[TBL] [Abstract][Full Text] [Related]
32. Gender differences in cardiac function during early remodeling after acute myocardial infarction in mice.
Cavasin MA; Tao Z; Menon S; Yang XP
Life Sci; 2004 Sep; 75(18):2181-92. PubMed ID: 15325844
[TBL] [Abstract][Full Text] [Related]
33. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host.
Szalay G; Sauter M; Haberland M; Zuegel U; Steinmeyer A; Kandolf R; Klingel K
Circ Res; 2009 Apr; 104(7):851-9. PubMed ID: 19246678
[TBL] [Abstract][Full Text] [Related]
34. [Association between wnt signal pathway and post-infarction cardiac remodeling/rupture in aged mice].
Huang Y; Ma YT; Yang YN; Liu F; Chen BD; Li XM
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Sep; 37(9):826-31. PubMed ID: 20128383
[TBL] [Abstract][Full Text] [Related]
35. RORγt-expressing cells attenuate cardiac remodeling after myocardial infarction.
Enomoto D; Matsumoto K; Yamashita T; Kobayashi A; Maeda M; Nakayama H; Obana M; Fujio Y
PLoS One; 2017; 12(8):e0183584. PubMed ID: 28827845
[TBL] [Abstract][Full Text] [Related]
36. Cell therapy limits myofibroblast differentiation and structural cardiac remodeling: basic fibroblast growth factor-mediated paracrine mechanism.
Fedak PW; Bai L; Turnbull J; Ngu J; Narine K; Duff HJ
Circ Heart Fail; 2012 May; 5(3):349-56. PubMed ID: 22508775
[TBL] [Abstract][Full Text] [Related]
37. Deficiency in TIMP-3 increases cardiac rupture and mortality post-myocardial infarction via EGFR signaling: beneficial effects of cetuximab.
Hammoud L; Lu X; Lei M; Feng Q
Basic Res Cardiol; 2011 May; 106(3):459-71. PubMed ID: 21243368
[TBL] [Abstract][Full Text] [Related]
38. Exogenous miR-29B Delivery Through a Hyaluronan-Based Injectable System Yields Functional Maintenance of the Infarcted Myocardium.
Monaghan MG; Holeiter M; Brauchle E; Layland SL; Lu Y; Deb A; Pandit A; Nsair A; Schenke-Layland K
Tissue Eng Part A; 2018 Jan; 24(1-2):57-67. PubMed ID: 28463641
[TBL] [Abstract][Full Text] [Related]
39. Soluble epoxide hydrolase inhibitors, t-AUCB, downregulated miR-133 in a mouse model of myocardial infarction.
Gui Y; Li D; Chen J; Wang Y; Hu J; Liao C; Deng L; Xiang Q; Yang T; Du X; Zhang S; Xu D
Lipids Health Dis; 2018 May; 17(1):129. PubMed ID: 29843720
[TBL] [Abstract][Full Text] [Related]
40. Post-transcriptional Regulation of MMP16 and TIMP2 Expression
Rak B; Mehlich D; Garbicz F; Domosud Z; Paskal W; Marczewska JM; Włodarski PK
Cancer Genomics Proteomics; 2017; 14(5):389-401. PubMed ID: 28871006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
